-

Q2 Update by PQE Group: Two Acquisitions’ Announcements With United Pharma Technologies Inc. & Quintian Pharma, and New Two Offices

FLORENCE, Italy--(BUSINESS WIRE)--The first half of 2022 has closed highly positively for PQE Group, the global women-owned quality consulting company for Lifesciences. The Italian parent Group, after having concluded 2021 with + 20% increase in revenues, confirms its development plan with the announcement of two acquisitions and a new legal entity in Melbourne (Australia) and a new office in Buenos Aires (Argentina).

As stated at the beginning of 2022, most of the global staff development plan has been implemented with almost 400 new hires around the world, 200 of which are located in Italy or the US, followed by the PQE Group Mexican Affiliate.

With a strong focus on the United States and Latin America, the company managed by Gilda D'Incerti has started the acquisition process of two firms, announcing the affiliation of United Pharma Technologies Inc., a service company based in New Jersey, and Quintian Pharma, based in Malta.

The M&A model of the company embraces the concept of a Federation rather than a classic acquisition, which aims to exchange shares with different entities in local markets all over the world to create close knit alliances, allowing to scale up projects’ staff and capabilities faster and more efficiently.

In our unique and different approach to M&A activities, we aim to engage with entrepreneurs and not just companies, bringing business development ideas to the table and acting as a whole organization by sharing the same vision, mission and network.” – Danilo Neri, Vice President Executive and Board Equity Partner at PQE Group.

Quintian Pharma, administered by Claude Vella Bonanno, is committed to providing services and support to the pharmaceutical industry, following all EU directives on new products. PQE Group will join the Board as main shareholder (51%) and support the strategic growth of the consulting agency specialized in applying EU Pharmacovigilance standards to clients in the Middle East.

United Pharma Technologies Inc., a service agency based in New Jersey – USA, was founded in 2014 and is currently managed by Vasantha Madasu, who will join PQE Group as a local partner in the US and Mexican affiliates and has been named Chief Talent Officer for the Americas.

Contacts

PQE Group – Press Office
+39 3491512075 | pressoffice@pqegroup.com

More News From PQE Group

PQE US, Inc. Receives “Best Life Sciences Company in Maryland” by Stellar Business Awards

ROCKVILLE, Md.--(BUSINESS WIRE)--PQE Group is proud to announce it has been honored with the Stellar Business “Best Life Sciences Company in Maryland” Award. Stellar Business Awards is a premier recognition platform celebrating outstanding businesses, entrepreneurs, and industry leaders across multiple sectors. Its mission is to honor innovation, leadership, and success, giving businesses the visibility and credibility they deserve. It honors outstanding businesses, entrepreneurs, and industry...

PQE Group Announces Release of 2024 Sustainability Report

FLORENCE, Italy--(BUSINESS WIRE)--PQE Group is pleased to announce it has completed and released its 2024 Sustainability Report, which represents a significant milestone for the company as it marks its second report and the first to cover its full global operations. Unlike the previous 2023 edition, which focused solely on its Italian branch, this report provides a comprehensive view of the company’s sustainability strategy and impact across all 23 countries where it operates. Its publication w...

PQE Group Joins Project-COMFORT to Advance Patient-Centric Blood Collection and Diagnostics

ROME--(BUSINESS WIRE)--PQE Group, a global consulting firm specializing in Life Sciences, is proud to contribute its expertise as a strategic partner in the Project-COMFORT consortium. This innovative public-private partnership, funded by Horizon Europe and supported by the Innovative Health Initiative Joint Undertaking (IHI JU), officially launched in November 2024, marking a transformative shift in blood collection and diagnostics. The ambitious 42-month project brings together 51 organizatio...
Back to Newsroom